SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (112036)8/17/2000 11:30:27 PM
From: Jenna   of 120523
 
VION.. By now everyone has seen the impressive gains from selected pharmaceutical/ and related companies.. ONXX twice in one week, BRL, ICN, MYL, VRTX.. MEDX and MYGN earnings plays up 400% and still making higher highs. AMRI was unreal. ADRX and TEVA solid as a rock for years. Maybe VION will get on the bandwagon now.

Vion Awarded National Cancer Institute Research Contract for Preliminary Studies of TAPET(R) Imaging of Tumors
- Memorial Sloan-Kettering Cancer Center and Vion to Collaborate on Research Effort -
NEW HAVEN, Conn., Aug. 9 /PRNewswire/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION - news) today announced that Memorial Sloan-Kettering Cancer Center (MSKCC) and Vion have been awarded a $141,000 research contract by the National Cancer Institute (NCI) to study the use of Vion's TAPET® bacterial vector technology (Tumor Amplified Protein Expression Therapy) for the diagnostic imaging of tumors. T

he focus of this joint effort by MSKCC and Vion is to perform a preliminary investigation of TAPET-based tumor diagnostic imaging in preclinical animal models, as well as to determine the suitability of this approach for tumor diagnosis based on defined molecular signatures.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News